UFP Technologies, Inc.
General ticker "UFPT" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $1.7B (TTM average)
UFP Technologies, Inc. follows the US Stock Market performance with the rate: 53.6%.
Estimated limits based on current volatility of 1.9%: low 287.60$, high 298.64$
Factors to consider:
- Total employees count: 4846 (+16.9%) as of 2025
- Top business risk factors: Product defects, Market competition, Cybersecurity threats, Geopolitical risks, Labor/talent shortage/retention
- Current price 13.3% above estimated high
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [172.69$, 257.48$]
- 2026-12-31 to 2027-12-31 estimated range: [177.62$, 263.96$]
Financial Metrics affecting the UFPT estimates:
- Negative: with PPE of 23.7 at the end of fiscal year the price was high
- Positive: 11.29 < Operating profit margin, % of 15.32
- Positive: 4.90 < Operating cash flow per share per price, % of 5.13
- Negative: negative Industry operating cash flow (median)
- Positive: 7.19 < Return on assets ratio (scaled to [-100,100]) of 9.44
- Positive: Inventory ratio change, % of -2.06 <= -1.30
- Positive: Industry inventory ratio change (median), % of 0.70 <= 1.15
- Negative: 0.33 < Interest expense per share per price, % of 0.55
Short-term UFPT quotes
Long-term UFPT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $399.93MM | $504.31MM | $602.76MM |
| Operating Expenses | $342.26MM | $423.42MM | $510.42MM |
| Operating Income | $57.66MM | $80.90MM | $92.34MM |
| Non-Operating Income | $-3.76MM | $-7.87MM | $-9.82MM |
| Interest Expense | $3.65MM | $8.06MM | $9.80MM |
| Income(Loss) | $53.90MM | $73.03MM | $82.51MM |
| Taxes | $8.98MM | $14.04MM | $14.20MM |
| Net Income(Loss)* | $44.92MM | $58.98MM | $68.31MM |
| Stockholders Equity | $286.09MM | $342.76MM | $423.88MM |
| Inventory | $70.19MM | $87.54MM | $86.86MM |
| Assets | $404.14MM | $629.00MM | $655.08MM |
| Operating Cash Flow | $41.33MM | $66.59MM | $91.91MM |
| Capital expenditure | $10.49MM | $9.66MM | $12.93MM |
| Investing Cash Flow | $-10.49MM | $-210.16MM | $-27.60MM |
| Financing Cash Flow | $-30.02MM | $152.39MM | $-58.16MM |
| Earnings Per Share** | $5.89 | $7.69 | $8.87 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.